Vandortuzumab (Anti-STEAP1)

Ask supplier a question | View on supplier's website

Vandortuzumab (Anti-STEAP1) is a recombinant monoclonal antibody that specifically targets STEAP1. It has potential for the treatment of prostate cancer. MW : 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2343
Sku #	A2343-1mg*25
Pricing	1mg*25, $5070.00

Feedback